Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million
Go back to Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million| (NYSE: BHVN) | Delayed: 14.85 +0.63 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.22 | 52 Week High | $ | |||
| Open | $14.42 | 52 Week Low | $ | |||
| Day High | $14.97 | P/E | N/A | |||
| Day Low | $14.22 | EPS | $ | |||
| Volume | 2,432,646 | |||||
